Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-type voltage-gated calcium channels (CaV2.2) are a subtype of high-voltage-activated (HVA) calcium channels predominantly found in the nervous system, especially at presynaptic nerve terminals and dendrites, as well as in neuroendocrine cells. These channels play a crucial role in mediating rapid calcium influx that triggers neurotransmitter release, synaptogenesis, gene expression, and are essential for normal synaptic transmission. They are validated targets for pain management and potential targets for neurological disorders involving synaptic dysfunction or hyperexcitability.
Inhibition of N-type voltage-gated calcium channels, preventing calcium influx and subsequent neurotransmitter release.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-type Voltage-Gated Calcium Channel (CaV2.2).